Folate transporter offers clues for anticancer drugs

Structural insights into a long-studied folate-transport protein provide evidence that might lead to entirely new targeted anticancer treatments, or boost the success of immunotherapy approaches to tackling tumours. Structure of the transporter SLC19A1 solved by cryo-electron microscopy.